13-valent pneumococcal conjugate vaccine (PCV13)
JMC Jefferies, E Macdonald, SN Faust… - Human …, 2011 - Taylor & Francis
The thirteen valent pneumococcal conjugate vaccine (PCV13, Prevenar 13Ô) is the broader
coverage successor to the highly effective seven valent vaccine (PCV7, PrevenarÔ) which …
coverage successor to the highly effective seven valent vaccine (PCV7, PrevenarÔ) which …
Safety of 13-valent pneumococcal conjugate vaccine in infants and children: meta-analysis of 13 clinical trials in 9 countries
A Thompson, A Gurtman, S Patterson, C Juergens… - Vaccine, 2013 - Elsevier
Background: Meta-analyses enable summarization and interpretation of data across clinical
trials. When applied to safety data they allow for detection of rare events. Recently, a 13 …
trials. When applied to safety data they allow for detection of rare events. Recently, a 13 …
Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe
RR Reinert, P Paradiso, B Fritzell - Expert Review of Vaccines, 2010 - Taylor & Francis
The 13-valent pneumococcal conjugate (PCV13, Prevenar 13®, Pfizer Inc., NY, USA) was
developed as a successor to the currently registered 7-valent pneumo coccal conjugate …
developed as a successor to the currently registered 7-valent pneumo coccal conjugate …
Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults
RA Gladstone, JM Jefferies, SN Faust… - Expert review of …, 2012 - Taylor & Francis
Pneumococcal disease remains a global problem despite the availability of effective
conjugate vaccines. The 13-valent pneumococcal conjugate vaccine (PCV13) extends the …
conjugate vaccines. The 13-valent pneumococcal conjugate vaccine (PCV13) extends the …
The 20-valent pneumococcal conjugate vaccine (PCV20): expected added value
E Janssens, J Flamaing, C Vandermeulen… - Acta Clinica …, 2023 - Taylor & Francis
Objectives Currently existing pneumococcal vaccines have contributed to a major reduction
in pneumococcal disease. However, there remains an unmet need for vaccine coverage of …
in pneumococcal disease. However, there remains an unmet need for vaccine coverage of …
13-Valent pneumococcal conjugate vaccine (PCV13) in children partially immunized with 7-valent pneumococcal conjugate vaccine (PCV7): a phase 3, open-label …
SA Silfverdal, CE Flodmark, L Rombo, SP Tansey… - Vaccine, 2013 - Elsevier
BACKGROUND: As 13-valent pneumococcal conjugate vaccine (PCV13) is introduced,
children who began vaccination with 7-valent pneumococcal conjugate vaccine (PCV7) may …
children who began vaccination with 7-valent pneumococcal conjugate vaccine (PCV7) may …
Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine
EC Dinleyici, ZA Yargic - Expert review of vaccines, 2009 - Taylor & Francis
The introduction of a 7-valent pneumococcal conjugate vaccine (PCV-7) into the routine
childhood vaccination schedule has been shown to be effective in preventing invasive …
childhood vaccination schedule has been shown to be effective in preventing invasive …
Update on the success of the pneumococcal conjugate vaccine
JD Kellner, Canadian Paediatric Society… - Paediatrics & child …, 2011 - academic.oup.com
Several years after the seven-valent pneumococcal conjugate vaccine (PCV7) was
introduced in Canada and elsewhere, routine infant vaccination has led to near eradication …
introduced in Canada and elsewhere, routine infant vaccination has led to near eradication …
Immunogenicity, safety and tolerability of 3 lots of 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in the United States
T Payton, D Girgenti, RW Frenck… - The Pediatric …, 2013 - journals.lww.com
Background: The 7-valent pneumococcal conjugate vaccine (PCV7; serotypes 4, 6B, 9V, 14,
18C, 19F and 23F) has decreased invasive pneumococcal disease incidence. This study …
18C, 19F and 23F) has decreased invasive pneumococcal disease incidence. This study …
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccines in Taiwan
LM Huang, TY Lin, C Juergens - Vaccine, 2012 - Elsevier
Immunogenicity and safety of 13-valent and 7-valent pneumococcal conjugate vaccines
(PCV13; PCV7) were compared in Taiwanese children. In this double-blind, multicenter …
(PCV13; PCV7) were compared in Taiwanese children. In this double-blind, multicenter …